Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: Relevance to schizophrenia

Neurobiology of Disease

Volumn 15, Issue 1, 2004, Pages 93-105

  Castagné, Vincent ^a   Rougemont, Michaël ^a   Cuenod, Michel ^a   Do, Kim Q ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

Ascorbic acid; Behaviour; Brain development; Cognitive deficit; Dopamine; Glutathione; Neurological evaluation; Object recognition memory; Oxidative stress; Schizophrenia

Indexed keywords

ASCORBIC ACID; BUTHIONINE SULFOXIMINE; DOPAMINE UPTAKE INHIBITOR; GLUTATHIONE; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; FEMALE; GLUTATHIONE METABOLISM; HYPERACTIVITY; MALE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT; SCHIZOPHRENIA;

EID: 1642497596     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.09.005     Document Type: Article

References (71)

1. Abbey H., Howard E. Statistical procedure in developmental studies on species with multiple offspring. Dev. Psychobiol. 6:1973;329-335.
2. Almaguer-Milian W., Cruz-Aguado R., Bergado J.A. Synaptic plasticity is impaired in rats with a low glutathione content. Synapse. 38:2000;369-374.
3. Astur R.S., Klein R.L., Mumby D.G., Protz D.K., Sutherland R.J., Martin G.M. A role for olfaction in object recognition by normal and hippocampal-damaged rats. Neurobiol. Learn. Mem. 78:2002;186-191.
4. Bats S., Thoumas J.L., Lordi B., Tonon M.C., Lalonde R., Caston J. The effects of a mild stressor on spontaneous alternation in mice. Behav. Brain Res. 118:2001;11-15.
5. Brown M.W., Aggleton J.P. Recognition memory: what are the roles of the perirhinal cortex and hippocampus? Nat. Rev., Neurosci. 2:2001;51-61.
6. Budygin E.A., Kilpatrick M.R., Gainetdinov R.R., Wightman R.M. Correlation between behavior and extracellular dopamine levels in rat striatum: comparison of microdialysis and fast-scan cyclic voltammetry. Neurosci. Lett. 281:2000;9-12.
7. Buonocore G., Perrone S., Bracci R. Free radicals and brain damage in the newborn. Biol. Neonate. 79:2001;180-186.
8. Bussey T.J., Muir J.L., Aggleton J.P. Functionally dissociating aspects of event memory: the effects of combined perirhinal and postrhinal cortex lesions on object and place memory in the rat. J. Neurosci. 19:1999;495-502.
9. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41:2001;237-260.
10. Castagné V., Maire J.C., Moënnoz D., Gyger M. Effect of threonine on the behavioural development of the rat. Pharmacol. Biochem. Behav. 52:1995;281-289.
11. Castagné V., Gautschi M., Lefèvre K., Posada A., Clarke P.G.H. Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog. Neurobiol. 59:1999;397-423.
12. Chan S.W., Reade P.C. Determination of the L-ascorbic acid requirements in Wistar osteogenic disorder Shionogi rats for prolonged carcinogenesis experiments. Lab. Anim. 30:1996;337-346.
13. Cruz-Aguado R., Almaguer-Melian W., Díaz C.M., Lorigados L., Bergado J. Behavioral and biochemical effects of glutathione depletion in the rat brain. Brain Res. Bull. 55:2001;327-333.
14. Cruz-Aguado R., Almaguer-Melian W., Díaz C.M., Lorigados L., Bergado J. Behavioral and biochemical effects of glutathione depletion in the rat brain. Brain Res. Bull. 55:2001;327-333.
15. Danion J.M., Rizzo L., Bruant A. Functional mechanisms underlying impaired recognition memory and conscious awareness in patients with schizophrenia. Arch. Gen. Psychiatry. 56:1999;639-644.
16. Dellu F., Mayo W., Cherkaoui J., Le Moal M., Simon H. A two-trial memory task with automated recording: study in young and aged rats. Brain Res. 588:1992;132-139.
17. Dellu F., Fauchey V., Le Moal M., Simon H. Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes. Neurobiol. Learn. Mem. 67:1997;112-120.
18. Do K.Q., Lauer C.J., Schreiber W., Zollinger M., Gutteck-Amsler U., Cuénod M., Holsboer F. Gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J. Neurochem. 65:1995;2652-2662.
19. Do K.Q., Trabesinger A.H., Kirsten-Krüger M., Lauer C.J., Dydak U., Hell D., Holsboer F., Boesiger P., Cuénod M. Schizophrenia: glutathione deficit in cerebro spinal fluid and prefrontal cortex in vivo. Eur. J. Neurosci. 12:2000;3721-3728.
20. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum. Dev. 3:1979;79-83.
21. Doniger G.M., Silipo G., Rabinowicz E.F., Snodgrass J.G., Javitt D.C. Impaired sensory processing as a basis for object-recognition deficits in schizophrenia. Am. J. Psychiatry. 158:2001;1818-1826.
22. Ellemberg D., Lewis T.L., Maurer D., Brent H.P. Influence of monocular deprivation during infancy on the later development of spatial and temporal vision. Vision Res. 40:2000;3283-3295.
23. Ennaceur A., Aggleton J.P. The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav. Brain Res. 88:1997;181-193.
24. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav. Brain Res. 31:1988;47-59.
25. Escorihuela R.M., Fernandez-Teruel A., Tobena A., Vivas N.M., Marmol F., Badia A., Dierssen M. Early environmental stimulation produces long-lasting changes on beta-adrenoceptor transduction system. Neurobiol. Learn. Mem. 64:1995;49-57.
26. Finlay J.M. Mesoprefrontal dopamine neurons and schizophrenia: role of developmental abnormalities. Schizophr. Bull. 27:2001;431-442.
27. Grima G., Benz B., Parpura V., Cuenod M., Do K.Q. Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophr. Res. 62:2003;213-224.
28. Gutteridge J.M., Halliwell B. Free radicals and antioxidants in the year. A historical look to the future 2000. Ann. N. Y. Acad. Sci. 899:2000;136-147.
29. Hastings T.G., Lewis D.A., Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U. S. A. 93:1996;1956-1961.
30. Heckers S., Curran T., Goff D., Rauch S.L., Fischman A.J., Alpert N.M., Schacter D.L. Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia. Biol. Psychiatry. 48:2000;651-657.
31. Herken H., Uz E., Ozyurt H., Sögüt S., Virit O., Kyol O. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol. Psychiatry. 6:2001;66-73.
32. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 13:1968;222-257.
33. Jenness R., Birney E.C., Ayaz K.L., Buzzell D.M. Ontogenetic development of L-gulonolactone oxidase activity in several vertebrates. Comp. Biochem. Physiol., B. 78:1984;167-173.
34. Kirkby R.J. A maturation factor in spontaneous alternation. Nature. 215:1967;784.
35. Kuperberg G., Heckers S. Schizophrenia and cognitive function. Curr. Opin. Neurobiol. 10:2000;205-210.
36. Lehmann J., Stöhr T., Feldon J. Long-term effects of prenatal stress experience and postnatal maternal separation on emotionality and attentional processes. Behav. Brain Res. 107:2000;133-144.
37. Levine M., Wang Y., Rumsey S.C. Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods Enzymol. 299:1999;65-76.
38. Lewis T.L., Ellemberg D., Maurer D., Wilkinson F., Wilson H.R., Dirks M., Brent H.P. Sensitivity to global form in glass patterns after early visual deprivation in humans. Vision Res. 42:2002;939-948.
39. Lou M.F. Thiol regulation in the lens. J. Ocul. Pharmacol. Ther. 16:2000;137-148.
40. Mahadik S.P., Mukherjee S., Scheffer R., Correnti E.E., Mahadik J.S. Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biol. Psychiatry. 43:1998;674-679.
41. Mahadik S.P., Evans D., Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 25:2001;463-493.
42. Marenco S., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol. 12:2000;501-527.
43. Martensson J., Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc. Natl. Acad. Sci. U. S. A. 88:1991;4656-4660.
44. Martensson J., Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc. Natl. Acad. Sci. U. S. A. 88:1991;4656-4660.
45. Martensson J., Meister A. Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11566-11568.
46. Martensson J., Meister A. Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11566-11568.
47. McCarty C.A., Wood C.A., Fu C.L., Livingston P.M., Mackersey S., Stanislavsky Y., Taylor H.R. Schizophrenia, psychotropic medication, and cataract. Ophthalmology. 106:1999;683-687.
48. Meister A. Glutathione biosynthesis and its inhibition. Methods Enzymol. 252:1995;26-30.
49. Milby K., Oke A.F., Adams R., Adams R.N. Detailed mapping of ascorbate distribution in rat brain. Neurosci. Lett. 28:1982;15-20.
50. Mumby D.G., Glenn M.J., Nesbitt C., Kyriazis D.A. Dissociation in retrograde memory for object discriminations and object recognition in rats with perirhinal cortex damage. Behav. Brain Res. 132:2002;215-226.
51. Nanda D., Tolputt J., Collard K.J. Changes in brain glutathione levels during postnatal development in the rat. Dev. Brain Res. 94:1996;238-241.
52. Nandi A., Mukhopadhyay C.K., Ghosh M.K., Chattopadhyay D.J., Chatterjee I.B. Evolutionary significance of vitamin C biosynthesis in terrestrial vertebrates. (see comments) Free Radic. Biol. Med. 22:1997;1047-1054.
53. Nishikimi M., Yagi K. Biochemistry and molecular biology of ascorbic acid biosynthesis. Subcell. Biochem. 25:1996;17-39.
54. O'Leary D.S., Flaum M., Kesler M.L., Flashman L.A., Arndt S., Andreasen N.C. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J. Neuropsychiatry Clin. Neurosci. 12:2000;4-15.
55. Parnas J., Bovet P., Innocenti G.M. Schizophrenic trait features, binding, and cortico-cortical connectivity: a neurodevelopmental pathogenic hypothesis. Neurol. Psychiatr., Brain Res. 4:1996;185-196.
56. Pryce C., Mohammed A., Feldon J. Environmental manipulations in rodents and primates. Insights into pharmacology, biochemistry and behaviour. Pharmacol. Biochem. Behav. 73:2002;1-5.
57. Rabinovic A.D., Hastings T.G. Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 71:1998;2071-2078.
58. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23:2000;209-216.
59. Rougemont M., Do K.Q., Castagné V. New model of glutathione deficit during development: effect on lipid peroxidation in the rat brain. J. Neurosci. Res. 70:2002;774-783.
60. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30:2001;1191-1212.
61. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267:2000;4904-4911.
62. Shukitt-Hale B., Denisova N.A., Strain J.G., Joseph J.A. Psychomotor effects of dopamine infusion under decreased glutathione conditions. Free Radic. Biol. Med. 23:1997;412-418.
63. Shukitt-Hale B., Erat S.A., Joseph J.A. Spatial learning and memory deficits induced by dopamine administration with decreased glutathione. Free Radic. Biol. Med. 24:1998;1149-1158.
64. Shukitt-Hale B., Erat S.A., Joseph J.A. Spatial learning and memory deficits induced by dopamine administration with decreased glutathione. Free Radic. Biol. Med. 24:1998;1149-1158.
65. Smart J.L. Vulnerability of developing brain to undernutrition. Upsala J. Med. Sci., Suppl. 48:1990;21-41.
66. Steullet P., Cuenod M., Do K.Q. Effect of glutathione deficit on neurotransmission and synaptic plasticity in rat hippocampus: relevance for schizophrenia. Schizophr. Res. 60:2003;261.
67. Tek C., Gold J., Blaxton T., Wilk C., McMahon R.P., Buchanan R.W. Visual perceptual and working memory impairments in schizophrenia. Arch. Gen. Psychiatry. 59:2002;146-153.
68. Wang Y., Kashiba M., Kasahara E., Tsuchiya M., Sato E.F., Utsumi K., Inoue M. Metabolic cooperation of ascorbic acid and glutathione in normal and vitamin C-deficient ODS rats. Physiol. Chem. Phys. Med. NMR. 33:2001;29-39.
69. Whimbey A.E., Denenberg V.H. Two independent behavioral dimensions in open-field performance. J. Comp. Physiol. Psychol. 63:1967;500-504.
70. Yao J.K., Reddy R.D., van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs. 15:2001;287-310.
71. Yao J.K., Leonard S., Reddy R.D. Reduced glutathione redox state in schizophrenia. (Abstract) J. Neurochem. 81(Suppl. 1):2002;22.